Lee Cooperman – DMAC history
- Issuer:
- DIAMEDICA THERAPEUTICS INC
- Quarters tracked:
- 22 (Q4 2020 → Q1 2026)
- Current shares:
- 2,020,000
- Current value:
- $13.68M
- Peak shares:
- 3,269,761 (Q3 2025)
- Overall change:
- +6633%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 2,020,000 | $13.68M | $6.77 | 0 | 0% |
| Q4 2025 | 2,020,000 | $16.08M | $7.96 | -1,249,761 | -38% |
| Q3 2025 | 3,269,761 | $17.64M | $5.40 | +1,619,761 | +98% |
| Q2 2025 | 1,650,000 | $6.43M | $3.90 | +25,000 | +2% |
| Q1 2025 | 1,625,000 | $6.16M | $3.79 | 0 | 0% |
| Q4 2024 | 1,625,000 | $8.82M | $5.43 | +113,261 | +7% |
| Q3 2024 | 1,511,739 | $6.33M | $4.19 | +111,739 | +8% |
| Q2 2024 | 1,400,000 | $4.13M | $2.95 | +516,377 | +58% |
| Q1 2024 | 883,623 | $2.45M | $2.77 | 0 | 0% |
| Q4 2023 | 883,623 | $2.51M | $2.84 | +7,630 | +1% |
| Q3 2023 | 875,993 | $2.26M | $2.58 | 0 | 0% |
| Q2 2023 | 875,993 | $3.78M | $4.32 | +7,580 | +1% |
| Q1 2023 | 868,413 | $1.33M | $1.53 | +55,905 | +7% |
| Q4 2022 | 812,508 | $1.28M | $1.58 | 0 | 0% |
| Q3 2022 | 812,508 | $1.01M | $1.24 | 0 | 0% |
| Q2 2022 | 812,508 | $1.64M | $2.02 | 0 | 0% |
| Q1 2022 | 812,508 | $2.03M | $2.50 | +512,508 | +171% |
| Q4 2021 | 300,000 | $1.12M | $3.73 | +100,000 | +50% |
| Q3 2021 | 200,000 | $802K | $4.01 | +150,000 | +300% |
| Q2 2021 | 50,000 | $223K | $4.46 | 0 | 0% |
| Q1 2021 | 50,000 | $458K | $9.16 | +20,000 | +67% |
| Q4 2020 | 30,000 | $304K | $10.13 | — | NEW |